BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 29251621)

  • 21. [The significance of dynamic detection of WT1 expression on patients of hematologic malignancy following allogeneic hematopoietic stem cell transplantation].
    Jin S; Liu DH; Xu LP; Chen H; Chen YH; Qin YZ; Liu YR; Liu KY; Huang XJ
    Zhonghua Nei Ke Za Zhi; 2008 Jul; 47(7):578-81. PubMed ID: 19035171
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative assessment of WT1 gene expression after allogeneic stem cell transplantation is a useful tool for monitoring minimal residual disease in acute myeloid leukemia.
    Candoni A; Tiribelli M; Toffoletti E; Cilloni D; Chiarvesio A; Michelutti A; Simeone E; Pipan C; Saglio G; Fanin R
    Eur J Haematol; 2009 Jan; 82(1):61-8. PubMed ID: 18801058
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Analysis of chimerism in patients with hematologic malignancies after allogeneic hematopoietic stem cell transplantation].
    Furukawa T; Hashimoto S; Inano K; Yamazaki F; Takeda H; Kakihara T; Yano T; Abe T; Higuchi W; Toba K; Takahashi M; Koike T; Aizawa Y
    Rinsho Ketsueki; 2001 Jun; 42(6):488-95. PubMed ID: 11505528
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monitoring of donor chimerism in sorted CD34+ peripheral blood cells allows the sensitive detection of imminent relapse after allogeneic stem cell transplantation.
    Bornhäuser M; Oelschlaegel U; Platzbecker U; Bug G; Lutterbeck K; Kiehl MG; Schetelig J; Kiani A; Illmer T; Schaich M; Theuser C; Mohr B; Brendel C; Fauser AA; Klein S; Martin H; Ehninger G; Thiede C
    Haematologica; 2009 Nov; 94(11):1613-7. PubMed ID: 19880783
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bone marrow CD34+ molecular chimerism as an early predictor of relapse after allogeneic stem cell transplantation in patients with acute myeloid leukemia.
    Malagola M; Polverelli N; Beghin A; Bolda F; Comini M; Farina M; Morello E; Radici V; Accorsi Buttini E; Bernardi S; Re F; Leoni A; Bonometti D; Brugnoni D; Lanfranchi A; Russo D
    Front Oncol; 2023; 13():1133418. PubMed ID: 36950550
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The clinical significance of interphase fluorescence in situ hybridization monitoring chimeric status after sex-mismatched allogeneic hematopoietic stem cell transplantation for leukemia].
    Liu Q; Song L; Zhang Y; Wei Y; Xu D; Sun J; Liu X; Xu B; Meng F; Zhou S
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Apr; 22(2):212-5. PubMed ID: 15793790
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of chimerism and minimal residual disease monitoring for relapse prediction after allogeneic stem cell transplantation for adult acute lymphoblastic leukemia.
    Terwey TH; Hemmati PG; Nagy M; Pfeifer H; Gökbuget N; Brüggemann M; Le Duc TM; le Coutre P; Dörken B; Arnold R
    Biol Blood Marrow Transplant; 2014 Oct; 20(10):1522-9. PubMed ID: 24907626
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Simultaneous Monitoring of Mutation and Chimerism Using Next-Generation Sequencing in Myelodysplastic Syndrome.
    Lee JM; Kim YJ; Park SS; Han E; Kim M; Kim Y
    J Clin Med; 2019 Nov; 8(12):. PubMed ID: 31795155
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rapid single nucleotide polymorphism based method for hematopoietic chimerism analysis and monitoring using high-speed droplet allele-specific PCR and allele-specific quantitative PCR.
    Taira C; Matsuda K; Yamaguchi A; Uehara M; Sugano M; Okumura N; Honda T
    Clin Chim Acta; 2015 May; 445():101-6. PubMed ID: 25797898
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chimerism Testing by Next Generation Sequencing for Detection of Engraftment and Early Disease Relapse in Allogeneic Hematopoietic Cell Transplantation and an Overview of NGS Chimerism Studies.
    Liacini A; Tripathi G; McCollick A; Gravante C; Abdelmessieh P; Shestovska Y; Mathew L; Geier S
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511573
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical Utility of Quantitative PCR for Chimerism and Engraftment Monitoring after Allogeneic Stem Cell Transplantation for Hematologic Malignancies.
    Ahci M; Stempelmann K; Buttkereit U; Crivello P; Trilling M; Heinold A; Steckel NK; Koldehoff M; Horn PA; Beelen DW; Fleischhauer K
    Biol Blood Marrow Transplant; 2017 Oct; 23(10):1658-1668. PubMed ID: 28603070
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of relapse after hematopoietic stem cell transplantation in childhood by monitoring of WT1 expression and chimerism.
    Woehlecke C; Wittig S; Sanft J; Kreyenberg H; Gruhn B
    J Cancer Res Clin Oncol; 2015 Jul; 141(7):1283-90. PubMed ID: 25617314
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular basis for therapeutic decisions in chronic myeloid leukemia patients after allogeneic bone marrow transplantation.
    Román J; Alvarez MA; Torres A
    Haematologica; 2000 Oct; 85(10):1072-82. PubMed ID: 11025600
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Donor Chimerism of B Cells and Nature Killer Cells Provides Useful Information to Predict Hematologic Relapse following Allogeneic Hematopoietic Stem Cell Transplantation.
    Jiang Y; Wan L; Qin Y; Wang X; Yan S; Xie K; Wang C
    PLoS One; 2015; 10(7):e0133671. PubMed ID: 26226104
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Significance of Monitoring Minimal Residual Disease by Flow Cytometry in Acute Leukemia Patients Underwent Nonmyeloablative Allo-HSCT].
    Liu XX; Liu TQ; Guo M; Sun QY; Qiao JH; Hu KX; Li BX; Yao B; Yu CL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Jun; 25(3):873-879. PubMed ID: 28641652
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Detection of bcr/abl fusion gene changes in patients with chronic myeloid leukemia after allo-HSCT by real-time quantitative reverse transcription polymerase chain reaction and its significance].
    Xue M; Wang HX; Duan LN; Yan HM; Zhu L; Liu J; Ding L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Dec; 16(6):1350-3. PubMed ID: 19099642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kinetics of chimerism during the early post-transplant period in pediatric patients with malignant and non-malignant hematologic disorders: implications for timely detection of engraftment, graft failure and rejection.
    Dubovsky J; Daxberger H; Fritsch G; Printz D; Peters C; Matthes S; Gadner H; Lion T; Muller-Bérat N
    Leukemia; 1999 Dec; 13(12):2059, 2060-9. PubMed ID: 10602430
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fluorescent in situ hybridization on flow-sorted cells as a tool for evaluating minimal residual disease or chimerism after allogenic bone marrow transplantation.
    Cotteret S; Belloc F; Boiron JM; Bilhou-Nabera C; Dumain P; Boyer C; Lacombe F; Reiffers J; Bernard P
    Cytometry; 1998 Oct; 34(5):216-22. PubMed ID: 9822307
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of minimal residual disease by real-time quantitative PCR of Wilms' tumor 1 expression in patients with acute myelogenous leukemia after allogeneic stem cell transplantation: correlation with flow cytometry and chimerism.
    Kwon M; Martínez-Laperche C; Infante M; Carretero F; Balsalobre P; Serrano D; Gayoso J; Pérez-Corral A; Anguita J; Díez-Martín JL; Buño I
    Biol Blood Marrow Transplant; 2012 Aug; 18(8):1235-42. PubMed ID: 22281301
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of Wilms' tumor 1 expression on outcome of patients undergoing allogeneic stem cell transplantation for AML.
    Duléry R; Nibourel O; Gauthier J; Elsermans V; Behal H; Coiteux V; Magro L; Renneville A; Marceau A; Boyer T; Quesnel B; Preudhomme C; Duhamel A; Yakoub-Agha I
    Bone Marrow Transplant; 2017 Apr; 52(4):539-543. PubMed ID: 28067876
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.